Shigella Sonnei 53G Human Infection Study in Kenyan Adults — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Shigella Sonnei 53G Human Infection Study in Kenyan Adults — Stella

Home/Shigellosis/

View on ClinicalTrials.gov

Recruiting

Back to Shigellosis trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Kenya

KEMRI-Wellcome Trust Research Programme, Kilifi

Key details

Phase

Early testing

Sponsor

University of Oxford

Collaborators

KEMRI-Wellcome Trust Collaborative Research Program, KEMRI United States Army Medical Research Directorate-Kenya

Enrollment target

~70 participants

Started

January 2025

Primary completion

April 2026

Age range

18 Years – 45 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.